• Home
  • Search
  • Hot-Spot-Guided Generative Deep Learning for Drug-Like PPI Inhibitor Design.
  • Cite Icon2
  • https://doi.org/10.1007/s12539-025-00756-wCopy DOI Icon

Hot-Spot-Guided Generative Deep Learning for Drug-Like PPI Inhibitor Design.

Show More
  • Abstract
  • Literature Map
  • References
  • Citations
  • Similar Papers
Abstract

Protein-protein interactions (PPIs) are essential therapeutic targets, yet their large and relatively flat interfaces hinder the development of small-molecule inhibitors. Traditional computational approaches rely heavily on existing chemical libraries or expert heuristics, restricting exploration of novel chemical space. To address these challenges, we present Hot2Mol, a generative deep learning framework for the de novo design of target-specific and drug-like PPI inhibitors. Hot2Mol captures crucial pharmacophoric features from hot-spot residues, allowing precise targeting of PPI interfaces while eliminating the need for known bioactive ligands. The framework integrates three main components: a conditional transformer for pharmacophore-guided, property-constrained molecular generation; an E(n)-equivariant graph neural network to ensure accurate spatial alignment with PPI hot-spot pharmacophores; a variational autoencoder to sample novel and diverse molecular structures. Comprehensive assessments demonstrate that Hot2Mol outperforms state-of-the-art models in binding affinity, drug-likeness, synthetic accessibility, novelty, and uniqueness. Molecular dynamics simulations further confirm the strong binding stability of generated compounds. Case studies underscore Hot2Mol's ability to design high-affinity and selective PPI inhibitors, highlighting its potential to accelerate rational PPI-targeted drug discovery.

Similar Papers
  • Research Article

Abstract A015: Design and deciphering of precision peptide inhibitors for cancer stemness using generative deep learning and molecular dynamics simulations

  • Dec 09, 2024
  • Molecular Cancer Therapeutics
  • Gurudeeban Selvaraj +2
  • Research Article

Fulcrum Occupancy-Leverage Perturbation Strategy Enables Rapid Discovery of Potent CDK2-Cyclin A2 Interaction Inhibitors.

  • Aug 19, 2025
  • Angewandte Chemie (International ed. in English)
  • Ge Sun +21
  • PDF
  • Research Article
  • Citations8

Selective inhibitors targeting Fis1/Mid51 protein-protein interactions protect against hypoxia-induced damage in cardiomyocytes

  • Dec 21, 2023
  • Frontiers in Pharmacology
  • Mulate Zerihun +1
  • PDF
  • Research Article
  • Citations270

Design of target specific peptide inhibitors using generative deep learning and molecular dynamics simulations

  • Feb 21, 2024
  • Nature communications
  • Sijie Chen +9
  • Research Article
  • Citations14

Benchmark Study Based on 2P2IDB to Gain Insights into the Discovery of Small-Molecule PPI Inhibitors.

  • Feb 08, 2018
  • The Journal of Physical Chemistry B
  • Zhe Wang +9
  • Research Article
  • Citations3

Integrated AI and machine learning pipeline identifies novel WEE1 kinase inhibitors for targeted cancer therapy.

  • Mar 19, 2025
  • Molecular diversity
  • Jaikanth Chandrasekaran +7
  • Research Article
  • Citations14

Single-Chain Lanthanide Luminescence Biosensors for Cell-Based Imaging and Screening of Protein-Protein Interactions.

  • Sep 01, 2020
  • iScience
  • Ting Chen +3
  • Front Matter

Exploration of (Ultra)Big Chemical Spaces.

  • Oct 01, 2025
  • Molecular informatics
  • José L Medina-Franco
  • Book Chapter
  • Citations2

Protein-Protein Interactions (PPIs) as an Alternative to Targeting the ATP Binding Site of Kinase

  • Jan 01, 2016
  • Sailu Sarvagalla +1
  • Book Chapter

Chapter 8. Bicyclic Peptide Inhibitors of Protein–Protein Interactions

  • Jan 01, 2020
  • Marina Buyanova +1
  • Research Article

An In Silico Analysis Integrating Bulk and Single-Cells RNA Sequencing to Study the Mechanistic Effects of Umbelliferone in COPD

  • Apr 08, 2025
  • Journal of Computational Biophysics and Chemistry
  • Shirsha Mitra +2
  • PDF
  • Research Article
  • Citations24

Chemically stable inhibitors of 14-3-3 protein–protein interactions derived from BV02

  • Jan 01, 2019
  • Journal of Enzyme Inhibition and Medicinal Chemistry
  • Leire Iralde-Lorente +9
  • Research Article
  • Citations4

Chemical Space Overlap with Critical Protein-Protein Interface Residues in Commercial and Specialized Small-Molecule Libraries.

  • Dec 20, 2018
  • ChemMedChem
  • Yubing Si +6
  • Research Article
  • Citations8

Optimization of the C2 substituents on the 1,4-bis(arylsulfonamido)naphthalene-N,N′-diacetic acid scaffold for better inhibition of Keap1-Nrf2 protein-protein interaction

  • Mar 22, 2023
  • European Journal of Medicinal Chemistry
  • Dhulfiqar.Ali Abed +5
  • Research Article

Druggability assessments of small peptides as protein-protein interaction inhibitors targeting EED-EZH2 binding within the Polycomb Repressive Complex 2 (PRC2), an epigenetic regulator.

  • Aug 15, 2025
  • Molecular diversity
  • Varun Thachan Kundil +5
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.